Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
01 2Symbiotec Pharmalab Private Limited
02 2Farmabios S.p.A.
03 2Aarti Pharmalabs Limited
04 2Cipla Ltd.
05 1Curia Spain S.A.U.
06 1Fagron Inc
07 2Hovione FarmaCiencia SA
08 4Industriale Chimica s.r.l.
09 1LETCO MEDICAL, LLC
10 1Medisca Inc.
11 1NEWCHEM SPA
12 1Professional Compounding Centers of America dba PCCA
13 1STERLING SPA
14 1SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD
15 2Sicor de Mexico S.A. de C.V
16 2Sterling S.p.A.
17 1zhejiang xianju pharmaceutical co., Ltd.
01 5MOMETASONE FUROATE
02 1MOMETASONE FUROATE MICRONIZED
03 2MOMETASONE FUROATE MONOHYDRATE
04 13Mometasone Furoate
05 5Mometasone Furoate Monohydrate
06 1mometasone furoate
01 1China
02 2Germany
03 6India
04 8Italy
05 1Malaysia
06 2Mexico
07 1Netherlands
08 2Portugal
09 3U.S.A
10 1United Kingdom
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
NDC Package Code : 22552-0002
Start Marketing Date : 2017-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Axplora is your partner of choice for complex APIs.
NDC Package Code : 46439-8733
Start Marketing Date : 2008-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0220
Start Marketing Date : 2006-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 22552-0021
Start Marketing Date : 2011-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Axplora is your partner of choice for complex APIs.
NDC Package Code : 46439-8781
Start Marketing Date : 2025-02-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 15308-2710
Start Marketing Date : 2006-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 50909-5152
Start Marketing Date : 2012-04-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50909-5151
Start Marketing Date : 2000-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2413
Start Marketing Date : 2014-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 24002-0004
Start Marketing Date : 2009-08-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
91
PharmaCompass offers a list of Mometasone Furoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mometasone Furoate manufacturer or Mometasone Furoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mometasone Furoate manufacturer or Mometasone Furoate supplier.
PharmaCompass also assists you with knowing the Mometasone Furoate API Price utilized in the formulation of products. Mometasone Furoate API Price is not always fixed or binding as the Mometasone Furoate Price is obtained through a variety of data sources. The Mometasone Furoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mometasone Furoate Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mometasone Furoate Monohydrate, including repackagers and relabelers. The FDA regulates Mometasone Furoate Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mometasone Furoate Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mometasone Furoate Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mometasone Furoate Monohydrate supplier is an individual or a company that provides Mometasone Furoate Monohydrate active pharmaceutical ingredient (API) or Mometasone Furoate Monohydrate finished formulations upon request. The Mometasone Furoate Monohydrate suppliers may include Mometasone Furoate Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Mometasone Furoate Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mometasone Furoate Monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mometasone Furoate Monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mometasone Furoate Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mometasone Furoate Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mometasone Furoate Monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mometasone Furoate Monohydrate suppliers with NDC on PharmaCompass.
We have 16 companies offering Mometasone Furoate Monohydrate
Get in contact with the supplier of your choice:
